New patent for Boehringer Ingelheim drug JENTADUETO XR

Annual Drug Patent Expirations for JENTADUETO+XR Jentadueto Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are eight…

Source


Comments are closed.

Biotechblog